(Q54416605)

29 May 2018

title

Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin. (English)

1 reference

29 May 2018

author name string

C Larsen

1

1 reference

29 May 2018

M Niebuhr Jørgensen

2

1 reference

29 May 2018

B Tommerup

3

1 reference

29 May 2018

N Mygind

4

1 reference

29 May 2018

E E Dagrosa

5

1 reference

29 May 2018

H G Grigoleit

6

1 reference

29 May 2018

V Malerczyk

7

1 reference

29 May 2018

publication date

1 January 1987

1 reference

29 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

29 May 2018

volume

33

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

155-159

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00544560

exact match

0 references

cites work

Significance of H and H receptors in the human nose: rationale for topical use of combined antihistamine preparations

1 reference

12 December 2020

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

12 December 2020

Rhinomanometry. I. Simple equipment.

1 reference

12 December 2020

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

1 reference

12 December 2020

Inhibition of ovulation in women by chronic treatment with a stimulatory lrh analogue — A new approach to birth control?

1 reference

12 December 2020

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

12 December 2020

Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

1 reference

12 December 2020

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

12 December 2020

Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment

1 reference

12 December 2020

Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma

1 reference

12 December 2020

Rhinomanometry. II. A system for numerical description of nasal airway resistance.

1 reference

12 December 2020

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

12 December 2020

Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone

1 reference

12 December 2020

Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?

1 reference

12 December 2020

LHRH-Agonist treatment in clinical and experimental human breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00544560

1 reference

29 May 2018

1 reference

29 May 2018